Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma

Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma

Purpose: Introduction of lenalidomide has expanded the therapeutic options for refractory and recurrent multiple myeloma (MM) patients. However, the application of the approved doses may be difficult in some patients due to adverse effects. Experimental design: Therefore, we evaluated the efficacy a...

Full description

Bibliographic Details
Main Authors: Schmidt-Wolf, Ingo G. H., Glasmacher, Axel, Gorschlüter, Marcus, Schwamborn, Katharina, German Refractory Myeloma Study Group
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2011-01-01
Series:GMS German Medical Science
Subjects:
myeloma
lenalidomide
dexamethasone
lymphoma
treatment
Online Access:http://www.egms.de/en/journals/gms/2011-9/000149.shtml

Internet

http://www.egms.de/en/journals/gms/2011-9/000149.shtml

Similar Items